Evergreening - Pharma

Please wait while the information is being loaded...

Relevant Publications

Development and approval of novel injectables: enhancing therapeutic innovations.

Issue Release: 2024

The impact of an \'evergreening\' strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands.

Issue Release: 2024

Assessment of the availability of repurposed orphan drugs in India.

Issue Release: 2023

Rise of escitalopram and the fall of citalopramh.

Issue Release: 2023

Humira: the first $20 billion drug.

Issue Release: 2023

The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy.

Issue Release: 2023

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic.

Issue Release: 2023

Crystallography of Contemporary Contact Insecticides.

Issue Release: 2022

Evergreened drugs or evergreened profits?

Issue Release: 2022

Patent \"Evergreening\" of Medicine-Device Combination Products: A Global Perspective.

Issue Release: 2022

Understanding \'Evergreening\': Making Minor Modifications Of Existing Medications To Extend Protections.

Issue Release: 2022

Evergreening of Psychiatric Medications: A Systemic Literature Review of Strategies, Case Examples, and the Implications of Cost.

Issue Release: 2022

Combination therapy patents: a new front in evergreening.

Issue Release: 2021

Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D.

Issue Release: 2020

In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development.

Issue Release: 2020

Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media.

Issue Release: 2019

Digital medicine systems: an evergreening strategy or an advance in medication management?

Issue Release: 2019

May your drug price be evergreen.

Issue Release: 2018

Ban evergreening and restricting generics to reduce drug prices, says US academy.

Issue Release: 2017

Allergan\'s Mohawk evergreening patent deal draws criticism, but ultimately may flop.

Issue Release: 2017

How Can ADEs be Prevented?

How Does the Patent System Affect Generic Competition?

What Should Be Included in Patient Education Materials?

What Roles Do Pharmacists Play in Pharma?

Why is Regulatory Approval Important?

Why do Pharma Companies Use CROs?

How Can Technology Aid in Management?

How Do Collaborative Care Models Work?

Who are Pharmacists?

What is Medication Management?

Partnered Content Networks

Relevant Topics